Grespo AB
Young biomedical company developing CNS treatments based on 2-oxoglutarate research.
Oversikt
- 0
- Ansatte
- ≤1t SEK
- Omsetning
- 2006
- Grunnlagt
Beskrivelse
Grespo is a young biomedical company based in Sweden specializing in the prevention and treatment of Central Nervous System (CNS) diseases. The core of their research focuses on leveraging the therapeutic effects of the substance 2-oxoglutarate (2-OX) within the body. Their primary clinical targets...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556710027501
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
ScandiBio Therapeutics AB
0 ansatteAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
LobSor Pharmaceuticals Aktiebolag
3 ansatteDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Umecrine Cognition AB
1–4 ansatteDeveloping novel drugs for neurological disorders caused by neuroinflammation.
AlzeCure Pharma AB
10–19 ansatteSwedish pharma developing CNS drugs for Alzheimer's and pain.
Polku Therapeutics Oy
Developing novel therapies for debilitating neurodegenerative diseases.
Utforsk mer
Spørsmål om Grespo AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo